Showing 1,121 - 1,140 results of 1,890 for search '"Type 2 diabetes"', query time: 0.21s Refine Results
  1. 1121

    PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice by Ying Sun, Zhanjun Jia, Gang Liu, Li Zhou, Mi Liu, Baoxue Yang, Tianxin Yang

    Published 2013-01-01
    “…Collectively, the present study demonstrated an inhibitory effect of PPARγ activation on renal mPGES-1/PGE2/EP4 pathway in type-2 diabetes and suggested that mPGES-1 may potentially serve as a therapeutic target for treating type-2 diabetes-associated DN.…”
    Get full text
    Article
  2. 1122

    Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications by Gabriele Togliatto, Patrizia Dentelli, Maria Felice Brizzi

    Published 2015-01-01
    “…Vascular complications are major causes of morbidity and mortality in type 2 diabetes patients. Mitochondrial reactive oxygen species (ROS) generation and a lack of efficient antioxidant machinery, a result of hyperglycaemia, mainly contribute to this problem. …”
    Get full text
    Article
  3. 1123

    Adipokines and Hepatic Insulin Resistance by Yu Li, Lin Ding, Waseem Hassan, Daoud Abdelkader, Jing Shang

    Published 2013-01-01
    “…Obesity is a major risk factor for insulin resistance and type 2 diabetes. Adipose tissue is now considered to be an active endocrine organ that secretes various adipokines such as adiponectin, leptin, resistin, tumour necrosis factor-α, and interleukin-6. …”
    Get full text
    Article
  4. 1124

    The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatment by Yi-Cheng Chang, Siow-Wey Hee, Meng-Lun Hsieh, Yung-Ming Jeng, Lee-Ming Chuang

    Published 2015-01-01
    “…The type 2 diabetes pandemic in recent decades is a huge global health threat. …”
    Get full text
    Article
  5. 1125

    Impaired Muscle Regeneration in Ob/ob and Db/db Mice by Mai-Huong Nguyen, Ming Cheng, Timothy J. Koh

    Published 2011-01-01
    “…In obesity and type 2 diabetes, efficient skeletal muscle repair following injury may be required, not only for restoring muscle structure and function, but also for maintaining exercise capacity and insulin sensitivity. …”
    Get full text
    Article
  6. 1126

    Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome by Tiziana Di Chiara, Christiano Argano, Salvatore Corrao, Rosario Scaglione, Giuseppe Licata

    Published 2012-01-01
    “…Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including visceral obesity, glucose intolerance or type 2 diabetes, elevated triglycerides, reduced HDL cholesterol, and hypertension. …”
    Get full text
    Article
  7. 1127

    102 Jurnal Kesehatan Andalas. 2015; 4(1) Pola Komplikasi Kronis Penderita Diabetes Melitus Tipe 2 Rawat Inap di Bagian Penyakit Dalam RS. Dr. M. Djamil Padang Januari 2011 - Desemb... by Dwi Amelisa Edwina, Asman Manaf, Efrida .

    Published 2015-01-01
    “…The objective of this study was to obtain a picture of the incidence of type 2 diabetic chronic complications. This descriptive study was conducted by taking medical record data of hospitalized type 2 diabetic patients with chronic complications inInternal Medicine Department Dr. …”
    Get full text
    Article
  8. 1128

    The causal relationship of cigarette smoking to metabolic disease risk and the possible mediating role of gut microbiota by Jingda Zhang, Lin Hou, Shanxiang Lei, Yan Li, Guogang Xu

    Published 2025-01-01
    “…In the MVMR model, the genetic connection between cigarette smoking, gut microbiota, and type 2 diabetes remained significant. Of note, paraprevotella_clara served an important mediating role in the type 2 diabetes associated with cigarette smoke. …”
    Get full text
    Article
  9. 1129

    Treatment of Heart Failure with Sodium-glucose Cotransporter Type 2 Inhibitors by Riber Fabián Donoso Noroña, Nairovys Gómez Martínez, Adisnay Rodríguez Plasencia

    Published 2024-09-01
    “…Sodium-glucose cotransporter type 2 inhibitors are a new class of drugs that have demonstrated cardiovascular benefits in patients with type 2 diabetes. The aim of the research was to gain insight into the efficacy of these drugs in the treatment of heart failure. …”
    Get full text
    Article
  10. 1130

    Quality of Life in University Students with Diabetes Distress: Type 1 and Type 2 of Diabetes Differences by Samah A. Moawd

    Published 2022-01-01
    “…This study constitutes a preliminary trial to clarify the relationship between quality of life (QoL) and diabetes distress (DD in patients with diabetes mellitus (DM) by comparing patients with type 1 and type 2 diabetes. Methods. A cross-sectional study of university students with diabetes (type 1 and type 2) diabetes. …”
    Get full text
    Article
  11. 1131

    The Associations of Parenting Factors with Adolescent Body Mass Index in an Underserved Population by Elizabeth M. Schneider, Dawn K. Wilson, Heather Kitzman-Ulrich, Sara M. St. George, Kassandra A. Alia

    Published 2013-01-01
    “…Validated measures of parental perceived child risk for development of type 2 diabetes mellitus, parental limit setting for sedentary behavior, and parental nurturance were evaluated as predictors of adolescent body mass index. …”
    Get full text
    Article
  12. 1132

    The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease by Claude Messier, Kevin Teutenberg

    Published 2005-01-01
    “…Most brain insulin comes from the pancreas and is taken up by the brain by what appears to be a receptor-based carrier. Type 2 diabetes animal models associated with insulin resistance show reduced insulin brain uptake and content. …”
    Get full text
    Article
  13. 1133

    Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different? by Chloé Amouyal, Fabrizio Andreelli

    Published 2016-01-01
    “…Bariatric surgery is now proposed during the therapeutic management of type 2 diabetes in obese or overweight populations. It has been hypothesized that restoration of endogenous GLP-1 secretion after the surgery may contribute to the postsurgical resolution of diabetes. …”
    Get full text
    Article
  14. 1134

    Physiological and pathophysiological actions of insulin in the liver by Naoto Kubota, Tetsuya Kubota, Takashi Kadowaki

    Published 2025-02-01
    “…Impaired insulin receptor signaling can cause hepatic insulin resistance and lead to type 2 diabetes. In the present study, we focus on a concept called “selective insulin resistance,” which has received increasing attention recently: the frequent coexistence of hyperglycemia and hepatic steatosis in people with type 2 diabetes and obesity suggests that it is possible for the insulin signaling regulating gluconeogenesis to be impaired even while that regulating lipogenesis is preserved, suggestive of selective insulin resistance. …”
    Get full text
    Article
  15. 1135

    A High-Fat Diet Causes Impairment in Hippocampal Memory and Sex-Dependent Alterations in Peripheral Metabolism by Erica L. Underwood, Lucien T. Thompson

    Published 2016-01-01
    “…While high-fat diets are associated with rising incidence of obesity/type-2 diabetes and can induce metabolic and cognitive deficits, sex-dependent comparisons are rarely systematically made. …”
    Get full text
    Article
  16. 1136

    Pharmacogenetics of Oral Antidiabetic Drugs by Matthijs L. Becker, Ewan R. Pearson, Ivan Tkáč

    Published 2013-01-01
    “…Oral antidiabetic drugs (OADs) are used for more than a half-century in the treatment of type 2 diabetes. Only in the last five years, intensive research has been conducted in the pharmacogenetics of these drugs based mainly on the retrospective register studies, but only a handful of associations detected in these studies were replicated. …”
    Get full text
    Article
  17. 1137

    The Construction of Regulatory Network for Insulin-Mediated Genes by Integrating Methods Based on Transcription Factor Binding Motifs and Gene Expression Variations by Hyeim Jung, Seonggyun Han, Sangsoo Kim

    Published 2015-09-01
    “…Type 2 diabetes mellitus is a complex metabolic disorder associated with multiple genetic, developmental and environmental factors. …”
    Get full text
    Article
  18. 1138

    Previous Gestational Diabetes Mellitus and Markers of Cardiovascular Risk by Nikolaos Vrachnis, Areti Augoulea, Zoe Iliodromiti, Irene Lambrinoudaki, Stavros Sifakis, George Creatsas

    Published 2012-01-01
    “…A history of previous GDM (pGDM), associated or not with any of these metabolic abnormalities, can increase the risk of developing not only type 2 diabetes mellitus but also cardiovascular disease (CVD) independent of a diagnosis of type 2 diabetes later in life. …”
    Get full text
    Article
  19. 1139

    Remodeling Intestinal Flora with Sleeve Gastrectomy in Diabetic Rats by Xiaofei Huang, Pan Weng, Huixin Zhang, Yingli Lu

    Published 2014-01-01
    “…As a complicated symbiotic system, intestinal flora is reported closely related to the development of type 2 diabetes recently. Sleeve gastrectomy is one of the approaches of bariatric surgery and could improve blood glucose control in type 2 diabetes patients. …”
    Get full text
    Article
  20. 1140